DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
HYPERICIN
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections; Lymphoma, T-Cell; Photochemotherapy; Psoriasis; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides
Unknown
HYPERICIN
×
Maximum Phase:
1
First Approval:
None
UNII:
7V2F1075HD
Molecule Type:
Small molecule
Molecular Formula:
C30H16O8
Molecular Weight:
504.45
AlogP:
5.08
PSA:
155.52
HBD:
6.0
HBA:
#RotB:
0.0
Source:
VINPOCETINE
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy; Diabetic Nephropathies; Attention Deficit Disorder with Hyperactivity
Unknown
VINPOCETINE
×
Maximum Phase:
1
First Approval:
None
UNII:
543512OBTC
Molecule Type:
Small molecule
Molecular Formula:
C22H26N2O2
Molecular Weight:
350.46
AlogP:
4.15
PSA:
34.47
HBD:
0.0
HBA:
#RotB:
3.0
Source:
JNJ-26483327
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Epidermal growth factor receptor erbB1 inhibitor
JNJ-26483327
×
Maximum Phase:
1
First Approval:
None
UNII:
16720VER1H
Molecule Type:
Small molecule
Molecular Formula:
C22H25BrN4O2
Molecular Weight:
457.37
AlogP:
5.14
PSA:
59.51
HBD:
1.0
HBA:
#RotB:
1.0
Source:
HYODEOXYCHOLIC_ACID
1
Small molecule
Investigational
Unknown
Unknown
Hypercholesterolemia
LXR-alpha agonist
HYODEOXYCHOLIC_ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
7A33Y6EHYK
Molecule Type:
Small molecule
Molecular Formula:
C24H40O4
Molecular Weight:
392.58
AlogP:
4.48
PSA:
77.76
HBD:
3.0
HBA:
#RotB:
4.0
Source:
CEP-37440
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
ALK tyrosine kinase receptor inhibitor
CEP-37440
×
Maximum Phase:
1
First Approval:
None
UNII:
O3MNS8782H
Molecule Type:
Small molecule
Molecular Formula:
C30H38ClN7O3
Molecular Weight:
580.13
AlogP:
3.84
PSA:
114.88
HBD:
4.0
HBA:
#RotB:
9.0
Source:
URAPIDIL HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Aortic Dissection
Unknown
URAPIDIL HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
PVU92PZO12
Molecule Type:
Small molecule
Molecular Formula:
C20H30ClN5O3
Molecular Weight:
423.95
AlogP:
0.72
PSA:
71.74
HBD:
1.0
HBA:
#RotB:
7.0
Source:
PYRUVATE SODIUM
1
Small molecule
Investigational
Unknown
Unknown
Asthma; Cystic Fibrosis; Severe Acute Respiratory Syndrome
Unknown
PYRUVATE SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
POD38AIF08
Molecule Type:
Small molecule
Molecular Formula:
C3H3NaO3
Molecular Weight:
110.04
AlogP:
-0.34
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
1.0
Source:
RALANITEN ACETATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RALANITEN ACETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
L10K286T2H
Molecule Type:
Small molecule
Molecular Formula:
C27H33ClO8
Molecular Weight:
521.01
AlogP:
4.44
PSA:
97.36
HBD:
0.0
HBA:
#RotB:
13.0
Source:
DWN-12088
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DWN-12088
×
Maximum Phase:
1
First Approval:
None
UNII:
TTU6QSK1G5
Molecule Type:
Small molecule
Molecular Formula:
C15H19Cl2N3O
Molecular Weight:
328.24
AlogP:
3.24
PSA:
50.08
HBD:
2.0
HBA:
#RotB:
4.0
Source:
AXT914
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AXT914
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BPI-9016
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms
Hepatocyte growth factor receptor inhibitor
BPI-9016
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GACYCLIDINE
1
Small molecule
Investigational
Unknown
Unknown
Tinnitus
Unknown
GACYCLIDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
9290ND070R
Molecule Type:
Small molecule
Molecular Formula:
C16H25NS
Molecular Weight:
263.45
AlogP:
4.64
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
2.0
Source:
AZD6280
1
Small molecule
Investigational
Unknown
Unknown
Anxiety
GABA receptor alpha-2 subunit positive allosteric modulator
AZD6280
×
Maximum Phase:
1
First Approval:
None
UNII:
B9Z1OEH19D
Molecule Type:
Small molecule
Molecular Formula:
C20H22N4O3
Molecular Weight:
366.42
AlogP:
3.04
PSA:
99.36
HBD:
2.0
HBA:
#RotB:
6.0
Source:
CONTELTINIB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CONTELTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
URX2UMQ8XV
Molecule Type:
Small molecule
Molecular Formula:
C32H45N9O3S
Molecular Weight:
635.84
AlogP:
3.84
PSA:
126.99
HBD:
4.0
HBA:
#RotB:
10.0
Source:
MEPHEDRONE
1
Small molecule
Investigational
Unknown
Unknown
Amphetamine-Related Disorders
Unknown
MEPHEDRONE
×
Maximum Phase:
1
First Approval:
None
UNII:
8BA8T27317
Molecule Type:
Small molecule
Molecular Formula:
C11H15NO
Molecular Weight:
177.25
AlogP:
1.79
PSA:
29.1
HBD:
1.0
HBA:
#RotB:
3.0
Source:
R-306465
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
R-306465
×
Maximum Phase:
1
First Approval:
None
UNII:
5WD7KK1IIQ
Molecule Type:
Small molecule
Molecular Formula:
C19H19N5O4S
Molecular Weight:
413.46
AlogP:
1.26
PSA:
115.73
HBD:
2.0
HBA:
#RotB:
4.0
Source:
INDIBULIN
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms
Tubulin inhibitor
INDIBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
80K4H2RB8P
Molecule Type:
Small molecule
Molecular Formula:
C22H16ClN3O2
Molecular Weight:
389.84
AlogP:
4.56
PSA:
63.99
HBD:
1.0
HBA:
#RotB:
5.0
Source:
GANTACURIUM
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GANTACURIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
N9VK9ZO25E
Molecule Type:
Small molecule
Molecular Formula:
C53H69ClN2O14+2
Molecular Weight:
993.59
AlogP:
7.84
PSA:
144.9
HBD:
0.0
HBA:
#RotB:
23.0
Source:
HM-71224
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HM-71224
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ICENTICAFTOR
1
Small molecule
Investigational
Unknown
Unknown
Bronchiectasis; Cystic Fibrosis; Liver Failure; Pulmonary Disease, Chronic Obstructive
Cystic fibrosis transmembrane conductance regulator activator
ICENTICAFTOR
×
Maximum Phase:
1
First Approval:
None
UNII:
AMB0BO0WFH
Molecule Type:
Small molecule
Molecular Formula:
C12H13F6N3O3
Molecular Weight:
361.24
AlogP:
1.73
PSA:
97.47
HBD:
3.0
HBA:
#RotB:
4.0
Source:
U-50488 METHANE SULFONATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
U-50488 METHANE SULFONATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C20H30Cl2N2O4S
Molecular Weight:
465.44
AlogP:
4.4
PSA:
23.55
HBD:
0.0
HBA:
#RotB:
4.0
Source:
KW-2478
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Myeloma
Unknown
KW-2478
×
Maximum Phase:
1
First Approval:
None
UNII:
E628ZH6U2C
Molecule Type:
Small molecule
Molecular Formula:
C30H42N2O9
Molecular Weight:
574.67
AlogP:
2.27
PSA:
127.23
HBD:
2.0
HBA:
#RotB:
16.0
Source:
ELSULFAVIRINE SODIUM
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
ELSULFAVIRINE SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
HKK2U3V1DT
Molecule Type:
Small molecule
Molecular Formula:
C24H16BrCl2FN3NaO5S
Molecular Weight:
651.27
AlogP:
5.96
PSA:
125.36
HBD:
2.0
HBA:
#RotB:
8.0
Source:
MERIMEPODIB
2
Small molecule
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Inosine-5'-monophosphate dehydrogenase 1 inhibitor
MERIMEPODIB
×
Maximum Phase:
2
First Approval:
None
UNII:
2ZL2BA06FU
Molecule Type:
Small molecule
Molecular Formula:
C23H24N4O6
Molecular Weight:
452.47
AlogP:
4.01
PSA:
123.95
HBD:
3.0
HBA:
#RotB:
7.0
Source:
DORAMAPIMOD
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Psoriasis
MAP kinase p38 alpha inhibitor
DORAMAPIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
HO1A8B3YVV
Molecule Type:
Small molecule
Molecular Formula:
C31H37N5O3
Molecular Weight:
527.67
AlogP:
5.99
PSA:
80.65
HBD:
2.0
HBA:
#RotB:
7.0
Source:
BISANTRENE
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Alpha-ketoglutarate-dependent dioxygenase FTO inhibitor
BISANTRENE
×
Maximum Phase:
2
First Approval:
None
UNII:
39C34M111K
Molecule Type:
Small molecule
Molecular Formula:
C22H22N8
Molecular Weight:
398.47
AlogP:
1.76
PSA:
97.56
HBD:
4.0
HBA:
#RotB:
4.0
Source:
CE-326597
2
Small molecule
Investigational
Unknown
Unknown
Obesity
Cholecystokinin A receptor agonist
CE-326597
×
Maximum Phase:
2
First Approval:
None
UNII:
1FGZ6L9SF2
Molecule Type:
Small molecule
Molecular Formula:
C37H34N6O2
Molecular Weight:
594.72
AlogP:
6.53
PSA:
87.12
HBD:
1.0
HBA:
#RotB:
8.0
Source:
AZD2516
2
Small molecule
Investigational
Unknown
Unknown
Gastroesophageal Reflux
Metabotropic glutamate receptor 5 negative allosteric modulator
AZD2516
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DECERNOTINIB
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Tyrosine-protein kinase JAK3 inhibitor
DECERNOTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
MZK2GP0RHK
Molecule Type:
Small molecule
Molecular Formula:
C18H19F3N6O
Molecular Weight:
392.39
AlogP:
3.28
PSA:
95.59
HBD:
3.0
HBA:
#RotB:
6.0
Source:
ACALISIB
2
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms
PI3-kinase p110-delta subunit inhibitor
ACALISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
OVW60IDW1D
Molecule Type:
Small molecule
Molecular Formula:
C21H16FN7O
Molecular Weight:
401.41
AlogP:
3.36
PSA:
101.38
HBD:
2.0
HBA:
#RotB:
4.0
Source:
ALANOSINE
2
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms
Unknown
ALANOSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
2CNI71214Y
Molecule Type:
Small molecule
Molecular Formula:
C3H7N3O4
Molecular Weight:
149.11
AlogP:
-1.23
PSA:
116.22
HBD:
3.0
HBA:
#RotB:
4.0
Source:
AVN-944
2
Small molecule
Investigational
Unknown
Unknown
Pancreatic Neoplasms
Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor
AVN-944
×
Maximum Phase:
2
First Approval:
None
UNII:
I3NPL1V48Q
Molecule Type:
Small molecule
Molecular Formula:
C25H27N5O5
Molecular Weight:
477.52
AlogP:
5.47
PSA:
138.51
HBD:
3.0
HBA:
#RotB:
9.0
Source:
LERIGLITAZONE
2
Small molecule
Investigational
Unknown
Unknown
Adrenoleukodystrophy; Friedreich Ataxia
Peroxisome proliferator-activated receptor gamma agonist
LERIGLITAZONE
×
Maximum Phase:
2
First Approval:
None
UNII:
K824X25AYA
Molecule Type:
Small molecule
Molecular Formula:
C19H20N2O4S
Molecular Weight:
372.45
AlogP:
2.65
PSA:
88.52
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PHOSPHOCREATINE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PHOSPHOCREATINE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INARIGIVIR SOPROXIL
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis B, Chronic
Unknown
INARIGIVIR SOPROXIL
×
Maximum Phase:
2
First Approval:
None
UNII:
365052M0DK
Molecule Type:
Small molecule
Molecular Formula:
C25H34N7O13PS
Molecular Weight:
703.62
AlogP:
0.27
PSA:
263.69
HBD:
4.0
HBA:
#RotB:
13.0
Source:
1
2
…
86
87
88
89
90
91
92
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA